Dexrazoxane preferentially mitigates doxorubicin cardiotoxicity in female children with sarcoma
Objective We sought to determine how sex and dexrazoxane therapy influence cardiac remodelling in children with sarcoma receiving high-dose doxorubicin.Methods In a retrospective cohort of 85 children with sarcoma receiving high-dose doxorubicin, echocardiography measures prior to, early after (with...
Saved in:
| Main Authors: | Hari K Narayan, Mary E Putt, Nikitha Kosaraju, Alejandro Paz, Shivani Bhatt, Theodore Plappert, Laura Mercer-Rosa, Saro H Armenian, Ami V Desai, Richard B Womer, Bonnie Ky |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-05-01
|
| Series: | Open Heart |
| Online Access: | https://openheart.bmj.com/content/6/1/e001025.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Can Dexrazoxane and Carvedilol prevent Doxorubicin-induced nephrotoxicity?
by: Szponar Jaroslaw, et al.
Published: (2024-12-01) -
Prevention of Heart Failure Induced by Doxorubicin with Early Administration of Dexrazoxane (PHOENIX Study): dose response and time course of dexrazoxane-induced degradation of topoisomerase 2b
by: Hui-Ming Chang, et al.
Published: (2025-05-01) -
Utilization of dexrazoxane in patients treated with doxorubicin: a retrospective, propensity matched analysis of cardiac function and toxicity
by: Zachary M. Neiman, et al.
Published: (2025-07-01) -
Pathophysiology of Doxorubicin-Mediated Cardiotoxicity
by: Roberto Arrigoni, et al.
Published: (2025-04-01) -
Dexrazoxane makes doxorubicin-induced heart failure a rare event in sarcoma patients receiving high cumulative doses
by: Haoyi Zheng, et al.
Published: (2025-03-01)